A Preexisting Rare PIK3CAE545K Subpopulation Confers Clinical Resistance to MEK plus CDK4/6 Inhibition in NRAS Melanoma and Is Dependent on S6K1 Signaling

Cancer Discovery
Gabriele RomanoLawrence N Kwong

Abstract

Combined MEK and CDK4/6 inhibition (MEKi + CDK4i) has shown promising clinical outcomes in patients with NRAS-mutant melanoma. Here, we interrogated longitudinal biopsies from a patient who initially responded to MEKi + CDK4i therapy but subsequently developed resistance. Whole-exome sequencing and functional validation identified an acquired PIK3CAE545K mutation as conferring drug resistance. We demonstrate that PIK3CAE545K preexisted in a rare subpopulation that was missed by both clinical and research testing, but was revealed upon multiregion sampling due to PIK3CAE545K being nonuniformly distributed. This resistant population rapidly expanded after the initiation of MEKi + CDK4i therapy and persisted in all successive samples even after immune checkpoint therapy and distant metastasis. Functional studies identified activated S6K1 as both a key marker and specific therapeutic vulnerability downstream of PIK3CAE545K-induced resistance. These results demonstrate that difficult-to-detect preexisting resistance mutations may exist more often than previously appreciated and also posit S6K1 as a common downstream therapeutic nexus for the MAPK, CDK4/6, and PI3K pathways.Significance: We report the first characterization of clinic...Continue Reading

References

Nov 18, 2005·The New England Journal of Medicine·John A CurtinBoris C Bastian
Jan 25, 2006·Proceedings of the National Academy of Sciences of the United States of America·Andreas G BaderPeter K Vogt
Jan 5, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kang-Yi SuPan-Chyr Yang
Jul 24, 2012·Cell·Eran HodisLynda Chin
Feb 23, 2013·Proceedings of the National Academy of Sciences of the United States of America·Christian PoschSusana Ortiz-Urda
Aug 2, 2013·Science Translational Medicine·Ryan B CorcoranJeffrey A Engelman
Nov 8, 2014·Neoplasia : an International Journal for Oncology Research·Silvina GrassoIsabel Martínez-Lacaci
Jan 30, 2015·Journal of Translational Medicine·Antonella MancaGiuseppe Palmieri
Jan 30, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M P MorelliS Kopetz
Apr 8, 2015·Nature Medicine·Hyo-eun C BhangFrank Stegmeier
Jun 20, 2015·Cell·UNKNOWN Cancer Genome Atlas Network
Oct 21, 2015·Nature Reviews. Clinical Oncology·Michael W SchmittJesse J Salk
Nov 8, 2015·Cancer Discovery·Mariangela RussoAlberto Bardelli
Dec 9, 2015·Cancer Discovery·Mariangela RussoRyan B Corcoran
Jul 22, 2017·Cancer Discovery·Nabil Amirouchene-AngelozziAlberto Bardelli

❮ Previous
Next ❯

Citations

Nov 6, 2018·Endocrine-related Cancer·Neil PortmanC Elizabeth Caldon
May 15, 2020·International Journal of Cancer. Journal International Du Cancer·Sofie NebenfuehrVeronika Sexl
Aug 16, 2019·Science Translational Medicine·Anna E VilgelmAnn Richmond
Jun 7, 2020·Acta Pharmacologica Sinica·Xia-Qing XuLing Ding
Oct 9, 2020·Expert Opinion on Pharmacotherapy·Maximilian JulveMark P Lythgoe
May 3, 2018·Cancer Discovery·Ryan J Sullivan
Jul 15, 2020·Cancer Immunology Research·Jessica L F TehAndrew E Aplin
Mar 2, 2019·Cancer Research·Tikvah K HayesCory M Johannessen
Oct 6, 2018·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jessica L F Teh, Andrew E Aplin
Apr 15, 2020·Cancer Cell·Mónica Álvarez-Fernández, Marcos Malumbres
Aug 1, 2018·Trends in Cell Biology·Shom GoelJean J Zhao
Mar 17, 2021·Journal for Immunotherapy of Cancer·Stanley LyVenkata Lokesh Battula
Jun 3, 2021·Life·Jiri Vachtenheim, Lubica Ondrušová
Jun 8, 2021·Cancer Treatment Reviews·Tijana RandicStephanie Kreis
Jun 10, 2021·Expert Reviews in Molecular Medicine·Marika A V Reinius, Elizabeth Smyth
Aug 13, 2021·Cancer Research·Anjali GeethadeviPradeep Chaluvally-Raghavan
Jan 14, 2022·Science·Anne FasslPiotr Sicinski

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Related Papers

Pharmacology & Therapeutics
Carolina Hertzman Johansson, Suzanne Egyhazi Brage
Rinshō shinkeigaku = Clinical neurology
Karen Nuytemans, Jeffery M Vance
The Lancet Oncology
Jeffrey R Infante, Charles Swanton
© 2022 Meta ULC. All rights reserved